US · Healthcare · Medical Care Facilities
EPS came in at -0.48 against a street estimate of -0.22 — a miss of 118.2%.
Analysts rate Community Health Systems Inc a hold (2 buy, 5 hold, 3 sell out of 10) with an average price target of $3.09.
CAUTIOUS CHS delivered solid volume growth but weaker payer and service mix pressured margins. Management cut 2026 revenue, EBITDA and cash-flow guidance while emphasizing cost savings and deferred elective demand. Q3 FY26 State-directed payment programs contributed no 2026 Florida benefit; prior-year Florida and Georgia benefits were partly offset by Indiana and Arizona true-ups. Analysts focused on elective-care deferrals, uninsured utilization, cash flow, cost savings and 2027 earnings. Management attributed weakness primarily to affordability-driven deferrals and highlighted operational cost controls. 2026-10-29…
Full summary in the app.
| Fund | Stake |
|---|---|
| CastleKnight Management LP | 9.49% |
| Apollo Management Holdings LP | 8.41% |
| BlackRock Inc | 7.75% |
| Eversept Partners, LP | 5.58% |
| Nomura Holdings Inc | 4.75% |
| Vanguard Capital Management, LLC | 3.75% |
| Whitebox Advisors, LLC | 2.65% |
| Geode Capital Management, LLC | 2.25% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Community Health Systems Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.